PBH Stock Forecast & Price Target

Prestige Consumer is a well-positioned company with a diverse portfolio of leading brands in niche healthcare categories and a strong presence in North America and other international markets. The recent divestiture of Shaw Bakers and potential sale of the PFD segment are positive catalysts that could lead to de-levering and a re-rating of the company's multiple, making it an attractive investment opportunity. While there may be some concerns around inflation and margins, we believe that PBH's track record of achieving top-line targets and its focus on cost-reduction efforts can drive future growth and improve margins.

Prestige Consumer is poised for modest accretion through 2027, as it adds capacity and recaptures lost margins, with accretive potential derived from such acquisitions and/or buybacks.. It also benefits from North America's very favorable healthcare market and diversified portfolio. However, a marginally high estimation of the Specialty Foods EBITDA, beef costs and corporate costs cast some Macris over its optimistic approach but the divestitures in 2026 show a promising year-ahead strategy.